• Immunostep Serology
  • Covid-19 Products
    • SARS-COV-2 Mpro ELISA IgA/IgG
    • SARS-CoV-2 Spike ELISA IgG
    • SARS-CoV-2 Multiplex IgG+IgA+IgM
  • Serology Blog
  • Contact
  • About Immunostep
  • Product Lines
    • Cell Analysis
    • Serology
    • Exosomes
  • English
  • Home
  • Covid-19 Products
    • SARS-COV-2 Mpro ELISA IgA/IgG
    • SARS-CoV-2 Spike ELISA IgG
    • SARS-CoV-2 Multiplex IgG+IgA+IgM
  • Serology Blog
  • Contact
  • About Immunostep
  • English
  • Exosomes
  • Serology
  • Cell Analysis

New serology Flow Cytometry Multiplex Assay for Covid-19

Posted in COVID-19, Press Release, Press Release.

►   Immunostep and the Spanish National Research Council (CSIC) announced the launch of a new serological test that differentiates vaccinated individuals from those who have suffered from Covid-19 natural...

Continue reading

New serological test with nearly 100% of accuracy.

Posted in Uncategorized.

▌ Immunostep and the Spanish National Research Council (CSIC) announced the launch of a new serological test with nearly 100% of accuracy. The test is based on non-structural proteins of the virus that...

Continue reading

Follow us on our networks and stay informed.

QUICK LINKS:

  • Overview
  • Covid-19 Products
    • SARS-COV-2 Mpro ELISA IgA/IgG
    • SARS-CoV-2 Spike ELISA IgG
    • SARS-CoV-2 Multiplex IgG+IgA+IgM
  • Serology Blog
  • support
  • Contact

LEGAL TEXTS:

  • Legal Notice
  • Privacy Policy
  • Cookies Policy

LOCATION:

Centro Investigación del Cáncer (C.I.C) Avda. Universidad de Coimbra, s/n Campus Miguel de Unamuno 37007 Salamanca

+34 923 294 827 

info@immunostep.com


© 2022 Immunostep

Website created & maintained by Especialistas Web

Download Paper:

Download | Single-reaction multi-antigen serological test for comprehensive evaluation of sars-cov-2 patients by flow cytometry.

    Read more about the research:

    Choose your Interests:

    I have read the Privacy Policy and accept the terms.
    I would like to recive occasional Serology News and Updates.